Agenus | AGEN - 资产



金融业
股票价格
USD 7.22
资产
USD 172.69M
现金及等价物
USD 18.74M
销售成本
USD 642K
流动资产
USD 78.81M
流动负债
USD 231.82M
债务
USD 35.54M
股息收益率
0
EBIT
USD 15.05M
EBITDA
USD -10.11M
员工
389
EPS每股收益
USD 1.02
股本和储备
USD -199.08M
销售毛利
USD 33.74M
债务利息支出
USD 14.67M
贷款资金
USD 153.99M
市值
USD 2.94B
净收入
USD 39.17M
营业费用
USD -199.08M
营业利润
USD 15.05M
普通股股本
USD 38.52M
PE价格收益
17.82
税前利润
USD 39.21M
销售收入
USD 33.7M
销售和管理费用
USD 6.21M
贸易债权人
USD 58.98M
应收帐款人
USD 22.34M


资产 更改 日
AbbVie USD 147.68B 12.57B 2026-09
Agenus USD 172.69M 13.76M 2026-06
Amgen USD 96.05B 409M 2026-09
AstraZeneca USD 119.92B 4.09B 2026-09
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Celldex Therapeutics USD 721.53M 60.82M 2026-09
CSL USD 37.9B 1.5B 2025-12
Eli Lilly USD 148.07B 5.79B 2026-09
Gilead Sciences USD 51.41B 2.05B 2026-09
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
Glaxosmithkline GBP 71.7B 8.83B 2026-09
Incyte USD 7.29B 585.39M 2026-09
Intrexon USD 73.16M 77.88M 2024-06
J&J USD 197.42B 3.64B 2026-09
Jiangsu Hengrui CNY 76.72B 5.95B 2026-09
Karyopharm Therapeutics USD 131.42M 23M 2026-03
MacroGenics USD 345.41M 127.54M 2026-06
Merck EUR 52.69B 383M 2026-06
Merck USD 132.77B 2.97B 2026-09
Northwest Biotherapeutics USD 80.05M 49.44M 2026-03
Novartis USD 117.15B 4.88B 2026-09
Novavax USD 888M 67.57M 2026-09
Pfizer USD 204.54B 3.41B 2026-09
Regeneron Pharmaceuticals USD 44.41B 2.67B 2026-09
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Veracyte USD 1.57B 86.89M 2026-09